Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


03.07.2017

2 Ann Neurol
2 BMC Neurol
2 Diabetes Res Clin Pract
2 J Autoimmun
2 J Clin Endocrinol Metab
1 J Immunol
1 Kidney Int
1 Lancet Infect Dis
6 Mult Scler
2 Neurology
10 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. TREMLETT H, Bauer KC, Appel-Cresswell S, Finlay BB, et al
    The gut microbiome in human neurological disease: A review.
    Ann Neurol. 2017;81:369-382.
    PubMed     Text format     Abstract available

  2. KIM TJ, Lee ST, Moon J, Sunwoo JS, et al
    Anti-LGI1 encephalitis is associated with unique HLA subtypes.
    Ann Neurol. 2017;81:183-192.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. HU B, Wu P, Zhou Y, Peng Y, et al
    A case of neuropsychiatric lupus Erythematosus characterized by the Owl's eye sign: a case report.
    BMC Neurol. 2017;17:123.
    PubMed     Text format     Abstract available

  4. COOTE S, Uszynski M, Herring MP, Hayes S, et al
    Effect of exercising at minimum recommendations of the multiple sclerosis exercise guideline combined with structured education or attention control education - secondary results of the step it up randomised controlled trial.
    BMC Neurol. 2017;17:119.
    PubMed     Text format     Abstract available


    Diabetes Res Clin Pract

  5. FORTIN A, Rabasa-Lhoret R, Roy-Fleming A, Desjardins K, et al
    Practices, perceptions and expectations for carbohydrate counting in patients with type 1 diabetes - Results from an online survey.
    Diabetes Res Clin Pract. 2017;126:214-221.
    PubMed     Text format     Abstract available

  6. CLAUDE MBANYA J, Aschner P, Chan JCN, Jose Gagliardino J, et al
    Self-monitoring of blood glucose (SMBG) and glycaemic control in Cameroon: Results of the International Diabetes Management Practices Study (IDMPS).
    Diabetes Res Clin Pract. 2017;126:198-201.
    PubMed     Text format     Abstract available


    J Autoimmun

  7. GIANFREDA D, Quaglini S, Frontini G, Raffiotta F, et al
    Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis?
    J Autoimmun. 2017 Jun 21. pii: S0896-8411(17)30359.
    PubMed     Text format     Abstract available

  8. TANSLEY SL, Simou S, Shaddick G, Betteridge ZE, et al
    Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.
    J Autoimmun. 2017 Jun 26. pii: S0896-8411(17)30170.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  9. RICKELS MR, Pelekis AJ, Markmann E, Dalton-Bakes C, et al
    Long-term improvement in glucose control and counterregulation by islet transplantation for type 1 diabetes.
    J Clin Endocrinol Metab. 2016 Aug 29:jc20161649.
    PubMed     Text format     Abstract available

  10. HANNA H, Paivi M, Jorma I, Paivi N, et al
    Clinical, genetic and biochemical characteristics of early-onset diabetes in the Finnish population.
    J Clin Endocrinol Metab. 2016 May 11:jc20154296.
    PubMed     Text format     Abstract available


    J Immunol

  11. YE J, Wang Y, Liu X, Li L, et al
    TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy.
    J Immunol. 2017 Jun 26. pii: ji1601890. doi: 10.4049/jimmunol.1601890.
    PubMed     Text format     Abstract available


    Kidney Int

  12. BOJIC M, Kozakowski N, Becede M, Kerschbaumer A, et al
    The Case | Myeloid bodies in the kidney biopsy of a patient with systemic lupus erythematosus.
    Kidney Int. 2017;92:271-272.
    PubMed     Text format    


    Lancet Infect Dis

  13. KEESEN TSL, de Almeida RP, Gois BM, Peixoto RF, et al
    Guillain-Barre syndrome and arboviral infection in Brazil.
    Lancet Infect Dis. 2017;17:693-694.
    PubMed     Text format    


    Mult Scler

  14. BOZ C, Terzi M, Zengin Karahan S, Sen S, et al
    Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis.
    Mult Scler. 2017 Jun 1:1352458517717806. doi: 10.1177/1352458517717806.
    PubMed     Text format     Abstract available

  15. RUANO L, Branco M, Portaccio E, Goretti B, et al
    Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study.
    Mult Scler. 2017 Jun 1:1352458517717341. doi: 10.1177/1352458517717341.
    PubMed     Text format     Abstract available

  16. HIDALGO DE LA CRUZ M, d'Ambrosio A, Valsasina P, Pagani E, et al
    Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis.
    Mult Scler. 2017 Jun 1:1352458517717807. doi: 10.1177/1352458517717807.
    PubMed     Text format     Abstract available

  17. WEYGANDT M, Wakonig K, Behrens J, Meyer-Arndt L, et al
    Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.
    Mult Scler. 2017 Jun 1:1352458517717089. doi: 10.1177/1352458517717089.
    PubMed     Text format     Abstract available

  18. YAP SM, McNicholas N, Hutchinson M, McGuigan C, et al
    Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis - Not always self-limiting, fully reversible or predictable.
    Mult Scler. 2017 Jun 1:1352458517719151. doi: 10.1177/1352458517719151.
    PubMed     Text format    

  19. RANGANATHAN U, Kaunzner U, Foster S, Vartanian T, et al
    Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.
    Mult Scler. 2017 Jun 1:1352458517719152. doi: 10.1177/1352458517719152.
    PubMed     Text format    


    Neurology

  20. LEWIS EJH, Perkins BA, Lovblom LE, Bazinet RP, et al
    Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial.
    Neurology. 2017;88:2294-2301.
    PubMed     Text format     Abstract available

  21. DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
    Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
    Neurology. 2017;88:2310-2320.
    PubMed     Text format     Abstract available


    PLoS One

  22. BACHELET D, Hassler S, Mbogning C, Link J, et al
    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
    PLoS One. 2016;11:e0162752.
    PubMed     Text format     Abstract available

  23. KREMER IE, Evers SM, Jongen PJ, van der Weijden T, et al
    Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling.
    PLoS One. 2016;11:e0164862.
    PubMed     Text format     Abstract available

  24. RYDEN A, Sorstadius E, Bergenheim K, Romanovschi A, et al
    The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
    PLoS One. 2016;11:e0164977.
    PubMed     Text format     Abstract available

  25. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Text format     Abstract available

  26. MARTIN P, McGovern A, Massey J, Schoenfelder S, et al
    Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C.
    PLoS One. 2016;11:e0166923.
    PubMed     Text format     Abstract available

  27. CHATTERJEE S, Bhardwaj N, Saxena RK
    Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.
    PLoS One. 2016;11:e0166878.
    PubMed     Text format     Abstract available

  28. VAN DALEM A, Demeester S, Balti EV, Keymeulen B, et al
    Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    PLoS One. 2016;11:e0166702.
    PubMed     Text format     Abstract available

  29. JOHNSON TW, Wu Y, Nathoo N, Rogers JA, et al
    Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0167196.
    PubMed     Text format     Abstract available

  30. PROSPERINI L, de Rossi N, Scarpazza C, Moiola L, et al
    Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    PLoS One. 2016;11:e0168376.
    PubMed     Text format     Abstract available

  31. ALROUGHANI R, Akhtar S, Ahmed S, Behbehani R, et al
    Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    PLoS One. 2016;11:e0165846.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: